46. Malignant rheumatoid arthritis Clinical trials / Disease details
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-jRCTs032180245 | 28/09/2012 | 12/03/2019 | Wear of 32mm OXINIUM head on XLPE: Multicenter RCT Study | Wear of 32mm Oxidized Zirconium (OXINIUM) head on Cross-linked Polyethylene in Primary Total Hip Arthroplasty: Multicenter Randomized controlled Trial Study - 32mmOX multicenter study | Hip osteoarthritis, Rheumatoid arthritis Hip osteoarthritis, Rheumatoid arthritis | Arm A: Oxidized zirconium alloy (OXINIUM) femoral head Arm B: Standard cobalt chromium alloy head Random allocation is registered automatically at the UMIN Internet Medical Research Data Center (INDICE) | Kume Shinichiro | NULL | Not Recruiting | >= 20age old | <= 75age old | Both | 352 | Phase 4 | Japan |
| 2 | JPRN-jRCTs032180273 | 11/07/2011 | 14/03/2019 | Wear of OXINIUM on XLPE: Multicenter RCT Study | Wear of Oxidized Zirconium (OXINIUM) on Cross-linked Polyethylene in Primary Total Hip Arthroplasty: Multicenter Randomized controlled Trial Study - 28mmOX multicenter study | Hip osteoarthritis, Rheumatoid arthritis Hip osteoarthritis, Rheumatoid arthritis | Arm A: Oxidized zirconium alloy (OXINIUM) femoral head Arm B: Standard cobalt chromium alloy head Random allocation is registered automatically at the UMIN Internet Medical Research Data Center (INDICE) | Akiyama Haruhiko | NULL | Not Recruiting | >= 20age old | <= 75age old | Both | 1308 | Phase 4 | Japan |
| 3 | NCT03681639 (ClinicalTrials.gov) | August 1, 2009 | 13/9/2018 | Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component | A Multi-Centre, Prospective Study to Obtain Survival and Clinical Outcome Data on the Zimmer Hip Resurfacing System Utilising the Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component | Avascular Necrosis of Hip;Osteoarthritis, Hip;Rheumatoid Arthritis;Inflammatory Arthritis;Post-traumatic; Arthrosis | Diagnostic Test: Serum Metal ion levels determined to monitor changes in chromium and cobalt levels | Zimmer Biomet | NULL | Active, not recruiting | 18 Years | 65 Years | All | 225 | N/A | Germany |
| 4 | NCT00589485 (ClinicalTrials.gov) | November 2006 | 21/12/2007 | Total Knee Replacement Using Simplex® or Cobalt™ Bone Cement | Total Knee Replacement Using Simplex® or Cobalt™ Bone Cement | Osteoarthritis;Rheumatoid Arthritis;Traumatic Arthritis;Knee Arthritis | Device: Simplex® Bone Cement;Device: Cobalt™ Bone Cement | Zimmer Biomet | New Lexington Clinic | Withdrawn | 18 Years | N/A | All | 0 | N/A | United States |